Revolutionising healthcare innovation: putting communities first

Season 3, Episode 7

The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) was launched in 2020 to promote solutions to mobility challenges faced by the MS community, and to increase awareness of the need for “outside-in” innovation that directly involves these communities from day-one.

This discussion includes the winner of the prize, a leader from the disability tech space, a leading patient advocates, the EU Commission, and Oxford’s leadership on the future of innovation in healthcare in a post-COVID era, and how we can work together to shape this.


Professor Chas Bountra, Professor of Translational Medicine; Chief Scientist, Structural Genomics Consortium Oxford

Chas is Pro-Vice Chancellor for Innovation and Professor of Translational Medicine at the University of Oxford. He is Director of the Centre for Medicines Discovery in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology.

Srin Madipalli, Global Accessibility Expert and Entrepreneur

Technology entrepreneur, investor and accessibility expert who founded a disability focused travel business that was acquired by Airbnb.


Donna Walsh, Executive Director, European Federation of Neurological Associations

Donna became the Executive Director of the European Federation of Neurological Associations [EFNA] and she has worked with patient organisations in the neurological sector – in various roles – since leaving university.

Maayan Ziv, Founder, CEO, AccessNow

Maayan Ziv, founder and CEO of AccessNow and winner of the Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis, is an activist, and an entrepreneur based in Toronto, Canada.

Pēteris Zilgalvis, Head of Digital Innovation and Blockchain

Pēteris Zilgalvis is the Head of Unit, Digital Innovation and Blockchain, DG CONNECT,  European Commission; Co-Chair, European Commission FinTech Task Force; Chair, European Commission Blockchain Competence Network.

Vreni Schoenenberger, Global Head of Public Affairs, Neuroscience, Novartis

Dr. Vreni Schoenenberger is the Global Head of Public Affairs, Neuroscience at the Basel-based Novartis Group.